Filing Details
- Accession Number:
- 0001708138-20-000030
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-04-03 16:50:23
- Reporting Period:
- 2020-04-01
- Accepted Time:
- 2020-04-03 16:50:23
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
872589 | Regeneron Pharmaceuticals Inc. | REGN | Pharmaceutical Preparations (2834) | 133444607 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1585160 | E Robert Landry | 777 Old Saw Mill River Road Tarrytown NY 10591 | Evp Finance Cfo | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2020-04-02 | 69 | $495.24 | 25,092 | No | 4 | S | Direct | |
Common Stock | Disposition | 2020-04-02 | 11 | $496.28 | 25,081 | No | 4 | S | Direct | |
Common Stock | Disposition | 2020-04-02 | 25 | $497.48 | 25,056 | No | 4 | S | Direct | |
Common Stock | Disposition | 2020-04-03 | 121 | $489.50 | 24,935 | No | 4 | S | Direct | |
Common Stock | Disposition | 2020-04-03 | 50 | $490.66 | 24,885 | No | 4 | S | Direct | |
Common Stock | Disposition | 2020-04-03 | 25 | $492.76 | 24,860 | No | 4 | S | Direct | |
Common Stock | Disposition | 2020-04-03 | 99 | $493.51 | 24,761 | No | 4 | S | Direct | |
Common Stock | Disposition | 2020-04-03 | 172 | $494.42 | 24,589 | No | 4 | S | Direct | |
Common Stock | Disposition | 2020-04-03 | 2 | $495.56 | 24,587 | No | 4 | S | Direct | |
Common Stock | Disposition | 2020-04-03 | 54 | $496.33 | 24,533 | No | 4 | S | Direct | |
Common Stock | Disposition | 2020-04-03 | 25 | $497.60 | 24,508 | No | 4 | S | Direct | |
Common Stock | Disposition | 2020-04-03 | 62 | $498.80 | 24,446 | No | 4 | S | Direct | |
Common Stock | Disposition | 2020-04-03 | 73 | $499.37 | 24,373 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2020-04-01 | 2,500 | $0.00 | 2,500 | $272.70 |
Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2020-04-01 | 2,000 | $0.00 | 2,000 | $272.70 |
Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2020-04-01 | 1,500 | $0.00 | 1,500 | $272.70 |
Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2020-04-02 | 3,000 | $0.00 | 3,000 | $272.70 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
52,000 | 2023-09-09 | No | 4 | M | Direct | |
50,000 | 2023-09-09 | No | 4 | M | Direct | |
48,500 | 2023-09-09 | No | 4 | M | Direct | |
45,500 | 2023-09-09 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock | 172 | Indirect | By 401(k) Plan |
Footnotes
- Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c).
- Represents volume-weighted average price of sales of 69 shares of Company stock on April 2, 2020 at prices ranging from $495.15 to $495.31. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on April 2, 2020 at each separate price.
- Represents volume-weighted average price of sales of 50 shares of Company stock on April 3, 2020 at prices ranging from $490.45 to $490.88. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on April 3, 2020 at each separate price.
- Represents volume-weighted average price of sales of 99 shares of Company stock on April 3, 2020 at prices ranging from $493.02 to $493.83. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on April 3, 2020 at each separate price.
- Represents volume-weighted average price of sales of 172 shares of Company stock on April 3, 2020 at prices ranging from $494.01 to $494.83. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on April 3, 2020 at each separate price.
- Represents volume-weighted average price of sales of 25 shares of Company stock on April 3, 2020 at prices ranging from $497.35 to $497.76. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on April 3, 2020 at each separate price.
- Represents volume-weighted average price of sales of 62 shares of Company stock on April 3, 2020 at prices ranging from $498.77 to $498.89. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on April 3, 2020 at each separate price.
- Represents volume-weighted average price of sales of 73 shares of Company stock on April 3, 2020 at prices ranging from $499.09 to $499.55. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on April 3, 2020 at each separate price.
- The stock option award vests in four equal annual installments, commencing one year after the date of grant.
- Form two of two